ZYMERON CORPORATION
Federal contract awards won by ZYMERON CORPORATION (UEI GAMMMRQ6QMN1), 2019–2024 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
19
awards
1
expiring in 12 months
2
agencies
Category award history
12 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: KONGSBERG DEFENCE & AEROSPACE AS took Department of Defense 541715 work from ZYMERON CORPORATION (Jan 14, 2026).
Agencies buying from ZYMERON CORPORATION
What ZYMERON CORPORATION has provided
Awards
DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS
Department of Defense · $2,999,983 · Sep 20, 2024
DHA STTR PH I PROPOSAL H23B-001-0020 ,TOPIC DHA23B-001-0020 TITLE AN AUTOMATED BLOOD-IN, MIRNAS-OUT ASSAY TO DETECT CIRCULATING AND EXOSOME MIRNAS EGS 2300543 MEDICAL R AND D
Department of Defense · $250,000 · Oct 6, 2023
DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK"
Department of Defense · $2,999,999 · Sep 15, 2023
ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT
Department of Defense · $250,000 · Jun 30, 2023
SBIR TOPIC 441. ZYMERON WILL DEVELOP USER-FRIENDLY TECHNOLOGIES AND DEVICES TO CREATE AN AT-HOME HEPATITIS C VIRUS TEST.
Department of Health and Human Services · $400,000 · Sep 19, 2022
AUTOMATED PARTIAL OCCLUSION FOR TRUNCAL HEMORRHAGE CONTROL SBIR PHASE II AWARD
Department of Defense · $989,815 · Aug 26, 2022
AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "NOVEL ANTIBIOTICS TARGETING MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA INFECTIONS"
Department of Defense · $1,100,000 · Jul 11, 2022
POINT-OF-CARE (POC) DIAGNOSTICS FOR ANTIMICROBIAL RESISTANT (AMR) ENTERIC BACTERIAL AND PARASITIC PATHOGENS
Department of Health and Human Services · $300,000 · Jul 1, 2022
AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME"
Department of Defense · $2,999,993 · Feb 7, 2022
ORODISPERSIBLE FILM OF SECOND LINE DRUG FOR PEDIATRIC TUBERCULOSIS TREATMENT.
Department of Health and Human Services · $300,000 · Sep 3, 2021
RAPID POINT OF CARE TESTS TO QUANTIFY HEPATITIS C VIRUS
Department of Health and Human Services · $300,000 · Aug 31, 2021
RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD.
Department of Health and Human Services · $1,272,000 · Aug 12, 2021
THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN, SYNTHESIZE COMPOUNDS THAT BIND TO NEF, AN HIV ACCESSORY PROTEIN.
Department of Health and Human Services · $300,000 · Jul 1, 2021
THE CONTRACTOR SHALL DEVELOP A NOVEL NANOPARTICLE DELIVERY SYSTEM TO ELICIT POTENT AND LONG-LASTING ANTIBODY RESPONSE AND BROADLY NEUTRALIZING ACTIVITY AGAINST HIV.
Department of Health and Human Services · $300,000 · Jul 1, 2021
THE CONTRACTOR SHALL PROPOSE NOVEL, LOW-COST, REAL-TIME POINT-OF-CARE (POC) ASSAYS FOR HIV VIRAL LOAD MONITORING, HIV DRUG RESISTANCE MONITORING, AND PHARMACOLOGICAL ADHERENCE MONITORING.
Department of Health and Human Services · $299,988 · Jul 1, 2021
MEDICAL RESEARCH AND DEVELOPMENT ARMY STTR PH II PROPOSAL NO. A2-8349 TITLED LONG LASTING DRUG IMPLANTS FOR MALARIA CHEMOPROPHYLAXIS.
Department of Defense · $1,099,999 · Feb 22, 2021
SBIR PHS 2020-1, TOPIC 084 ENTITLED "ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION"
Department of Health and Human Services · $300,000 · Aug 21, 2020
THE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A NOVEL HIV VACCINE CO-DELIVERY SYSTEM: AN INJECTABLE THERMOSENSITIVE HYDROGEL ENCAPSULATING POLYROTAXANE (PRX)-BASED SARNA (PRX-SARNA) NANOPARTICLES AND CYTOKINE ADJUVANT GM-CSF FOR TARGETED DELIVERY TO A
Department of Health and Human Services · $300,000 · Jun 1, 2020
COMPLETE SBIR TOPIC 46 PHASE II TASKS
Department of Health and Human Services · $1,500,000 · Aug 1, 2019